Kariya Pharmaceuticals ApS — Credit Rating and Financial Key Figures
CVR number: 39270684
Ole Maaløes Vej 3, 2200 København N
www.kariyapharma.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -6 324.85 | -1 493.45 | -2 712.24 | -13 798.22 | -10 223.06 |
| Employee benefit expenses | - 706.91 | -1 814.72 | - 505.58 | -13.66 | -66.55 |
| Total depreciation | -7.81 | -7.81 | -7.81 | ||
| EBIT | -7 031.76 | -3 315.98 | -3 225.63 | -13 819.70 | -10 289.62 |
| Other financial income | 0.20 | 4.89 | 6.60 | 199.63 | |
| Other financial expenses | - 272.52 | - 524.33 | - 648.60 | - 811.51 | -1 803.27 |
| Pre-tax profit | -7 304.28 | -3 840.11 | -3 869.34 | -14 624.60 | -11 893.25 |
| Income taxes | 1 632.96 | 614.26 | 619.03 | 3 870.70 | |
| Net earnings | -7 304.28 | -2 207.15 | -3 255.08 | -14 005.57 | -8 022.55 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 23.44 | 15.63 | 7.81 | ||
| Tangible assets total | 23.44 | 15.63 | 7.81 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 43.75 | ||||
| Current owed by particip. interest comp. | 48.00 | ||||
| Prepayments and accrued income | 390.49 | 6.71 | 43.43 | ||
| Current other receivables | 2 404.42 | 187.94 | 75.91 | 1 412.68 | 482.57 |
| Short term receivables total | 2 404.42 | 578.42 | 130.62 | 1 412.68 | 569.75 |
| Cash and bank deposits | 750.92 | 1 089.23 | 913.33 | 792.18 | 1 481.61 |
| Cash and cash equivalents | 750.92 | 1 089.23 | 913.33 | 792.18 | 1 481.61 |
| Balance sheet total (assets) | 3 178.77 | 1 683.28 | 1 051.76 | 2 204.86 | 2 051.35 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 0.10 | 0.10 | 40.00 | 40.00 | 45.82 |
| Retained earnings | -7 304.28 | -9 511.42 | -12 766.50 | 1 588.25 | |
| Profit of the financial year | -7 304.28 | -2 207.15 | -3 255.08 | -14 005.57 | -8 022.55 |
| Shareholders equity total | -7 304.18 | -9 511.32 | -12 726.50 | -26 732.07 | -6 388.47 |
| Non-current loans from credit institutions | 10 268.22 | 10 781.63 | 11 320.71 | 11 886.75 | |
| Non-current liabilities total | 10 268.22 | 10 781.63 | 11 320.71 | 11 886.75 | |
| Current trade creditors | 47.99 | 201.67 | 15 280.06 | 7 424.83 | |
| Current owed to participating | 2.14 | 2.81 | 2 217.68 | 1 745.12 | 1 001.73 |
| Other non-interest bearing current liabilities | 164.60 | 410.17 | 38.19 | 25.00 | 13.27 |
| Current liabilities total | 214.73 | 412.97 | 2 457.54 | 17 050.18 | 8 439.83 |
| Balance sheet total (liabilities) | 3 178.77 | 1 683.28 | 1 051.76 | 2 204.86 | 2 051.35 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.